| 摘要 |
<p>H~krlitelwovel /NRPorfl/hDCC/AAR/53,5_1I.DOC-Vi4/2lr3 26b The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolipids and antigen. The said compounds are also able to target drug to CDId restricted cells.</p> |
